254 related articles for article (PubMed ID: 14596627)
1. Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France.
de Zelicourt M; Dardennes R; Verdoux H; Gandhi G; Khoshnood B; Chomette E; Papatheodorou ML; Edgell ET; Even C; Fagnani F
Pharmacoeconomics; 2003; 21(15):1081-90. PubMed ID: 14596627
[TBL] [Abstract][Full Text] [Related]
2. [Bipolar I disorder in France: prevalence of manic episodes and hospitalisation-related costs].
de Zélicourt M; Dardennes R; Verdoux H; Gandhi G; Papatheodorou ML; Edgell ET; Khoshnood B; Chomette E; Even C; Fagnani F
Encephale; 2003; 29(3 Pt 1):248-53. PubMed ID: 12876549
[TBL] [Abstract][Full Text] [Related]
3. The real world cost and health resource utilization associated to manic episodes: The MANACOR study.
Hidalgo-Mazzei D; Undurraga J; Reinares M; Bonnín Cdel M; Sáez C; Mur M; Nieto E; Vieta E
Rev Psiquiatr Salud Ment; 2015; 8(2):55-64. PubMed ID: 25752959
[TBL] [Abstract][Full Text] [Related]
4. In-patient care costs of patients with bipolar I disorder: a comparison between two European centers.
Gonzalez-Pinto AM; Dardennes R; de Zélicourt M; López P; Oliveros RG; Vieta E; Barbeito S; Echevarria E; Fagnani F
J Affect Disord; 2010 Feb; 121(1-2):152-5. PubMed ID: 19482360
[TBL] [Abstract][Full Text] [Related]
5. Costs of bipolar disorder.
Kleinman L; Lowin A; Flood E; Gandhi G; Edgell E; Revicki D
Pharmacoeconomics; 2003; 21(9):601-22. PubMed ID: 12807364
[TBL] [Abstract][Full Text] [Related]
6. The societal cost of bipolar disorder in Sweden.
Ekman M; Granström O; Omérov S; Jacob J; Landén M
Soc Psychiatry Psychiatr Epidemiol; 2013 Oct; 48(10):1601-10. PubMed ID: 23754681
[TBL] [Abstract][Full Text] [Related]
7. Manic episodes: the direct cost of a three-month period following hospitalisation.
Olié JP; Lévy E
Eur Psychiatry; 2002 Sep; 17(5):278-86. PubMed ID: 12381498
[TBL] [Abstract][Full Text] [Related]
8. National estimates of the inpatient burden of pediatric bipolar disorder in the United States.
Berry EA; Heaton PT; Kelton CM
J Ment Health Policy Econ; 2011 Sep; 14(3):115-23. PubMed ID: 22116169
[TBL] [Abstract][Full Text] [Related]
9. Health care resource utilization and costs in a commercially insured population of patients with bipolar disorder type I and frequent psychiatric interventions.
Bagalman E; Muser E; Choi JC; Durden E; Macfadden W; Haskins JT; Dirani R
Clin Ther; 2011 Oct; 33(10):1381-1390.e4. PubMed ID: 22000656
[TBL] [Abstract][Full Text] [Related]
10. The cost of relapse for patients with a manic/mixed episode of bipolar disorder in the EMBLEM study.
Hong J; Reed C; Novick D; Haro JM; Windmeijer F; Knapp M
Pharmacoeconomics; 2010; 28(7):555-66. PubMed ID: 20405969
[TBL] [Abstract][Full Text] [Related]
11. The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998.
Begley CE; Annegers JF; Swann AC; Lewis C; Coan S; Schnapp WB; Bryant-Comstock L
Pharmacoeconomics; 2001; 19(5 Pt 1):483-95. PubMed ID: 11465308
[TBL] [Abstract][Full Text] [Related]
12. Annual cost of bipolar disorder to UK society.
Das Gupta R; Guest JF
Br J Psychiatry; 2002 Mar; 180():227-33. PubMed ID: 11872515
[TBL] [Abstract][Full Text] [Related]
13. Comparison of rapid-cycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients.
Kupka RW; Luckenbaugh DA; Post RM; Suppes T; Altshuler LL; Keck PE; Frye MA; Denicoff KD; Grunze H; Leverich GS; McElroy SL; Walden J; Nolen WA
Am J Psychiatry; 2005 Jul; 162(7):1273-80. PubMed ID: 15994709
[TBL] [Abstract][Full Text] [Related]
14. Cost effectiveness of olanzapine in prevention of affective episodes in bipolar disorder in the United Kingdom.
McKendrick J; Cerri KH; Lloyd A; D'Ausilio A; Dando S; Chinn C
J Psychopharmacol; 2007 Aug; 21(6):588-96. PubMed ID: 17050661
[TBL] [Abstract][Full Text] [Related]
15. Costs associated with attempted suicide among individuals with bipolar disorder.
Stensland MD; Zhu B; Ascher-Svanum H; Ball DE
J Ment Health Policy Econ; 2010 Jun; 13(2):87-92. PubMed ID: 20919595
[TBL] [Abstract][Full Text] [Related]
16. Hospitalisation costs of metastatic melanoma in France; the MELISSA study (MELanoma In hoSpital coSts Assessment).
Fernandes J; Bregman B; Combemale P; Amaz C; de Léotoing L; Vainchtock A; Gaudin AF
BMC Health Serv Res; 2017 Aug; 17(1):542. PubMed ID: 28789648
[TBL] [Abstract][Full Text] [Related]
17. Healthcare cost, service use and mortality in major psychiatric disorders in Taiwan.
Pan YJ; Kuo KH; Yeh LL
J Affect Disord; 2019 Mar; 246():112-120. PubMed ID: 30580196
[TBL] [Abstract][Full Text] [Related]
18. Annual cost of managing bipolar disorder to the UK healthcare system.
Young AH; Rigney U; Shaw S; Emmas C; Thompson JM
J Affect Disord; 2011 Oct; 133(3):450-6. PubMed ID: 21737141
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic treatment adherence and associated mental health care use among individuals with bipolar disorder.
Gianfrancesco FD; Sajatovic M; Rajagopalan K; Wang RH
Clin Ther; 2008 Jul; 30(7):1358-74. PubMed ID: 18691997
[TBL] [Abstract][Full Text] [Related]
20. Cost of depression in Europe.
Sobocki P; Jönsson B; Angst J; Rehnberg C
J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
